What You Should Know:
– Diaceutics, a leading technology and solutions provider to the life science industry, and Cornerstone AI, a leading AI-based data quality and data enhancement platform, today announced a strategic partnership to enhance the accuracy, completeness, and usability of data from the DXRX laboratory network.
– The collaboration integrates Cornerstone AI’s proprietary lab data algorithms with Diaceutics’ real-world data ecosystem, generating LOINC assignments to deliver faster, more accurate, and clinically meaningful insights.
Advancing Precision Medicine Through High-Fidelity Data Solutions
The implementation of precision medicine has been hindered by fragmented and inconsistent laboratory data. Addressing this challenge, Diaceutics and Cornerstone AI have partnered to enhance data quality and integrity, providing pharmaceutical, biotech, and diagnostics companies with a robust foundation for clinical development, faster market access, and improved patient outcomes. This collaboration delivers transformative value across the healthcare ecosystem.
Diaceutics is a leading provider of precision medicine solutions, offering:
- Real-world data insights to bridge the gap between biomarker testing and targeted therapies.
- Diagnostic testing expertise to optimize patient outcomes and support the life sciences industry in advancing personalized healthcare.
Cornerstone AI contributes its cutting-edge data quality and enhancement technology, enabling:
- Efficient resolution of data inconsistencies in laboratory data.
- Acceleration of targeted therapy development, ensuring faster delivery of critical treatments to patients.
Viraj Narayanan, CEO of Cornerstone AI, emphasized the synergy of this partnership, stating that Diaceutics’ commitment to leveraging real-world data aligns seamlessly with Cornerstone AI’s mission to enhance precision medicine. Together, the organizations aim to deliver high-fidelity data for pharmaceutical and biotech stakeholders, fostering:
- Comprehensive insights derived from laboratory information.
- Patient-centric innovation that accelerates the delivery of transformative treatments worldwide.
By addressing data inconsistencies and enhancing the interpretability of laboratory information, Diaceutics and Cornerstone AI are driving advancements in precision medicine, empowering stakeholders to succeed in the evolving landscape of personalized healthcare.
